13 articles for SC Goodacre
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1.

TBA
Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disorders.

Merck Sharp Laboratory
Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors.

Merck Sharp and Dohme Research Laboratories
Imidazo[1,2-a]pyrimidines as functionally selective GABA(A) ligands.

Merck Sharp and Dohme Research Laboratories
Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.

Merck Sharp and Dohme Research Laboratories
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling.

Genentech
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles.

Merck Sharp & Dohme Research Laboratories
TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Shanghaitech University
Benzenesulfonylbenazamide compound for inhibiting BCL-2 protein and composition and use thereof

Shenzhen Targetrx
Urease inhibitors from Hypericum oblongifolium WALL.

University of Peshawar
In silico binding analysis and SAR elucidations of newly designed benzopyrazine analogs as potent inhibitors of thymidine phosphorylase.

Universiti Teknologi Mara (Uitm)
Pyrazolopyrimidine JAK inhibitor compounds and methods

Genentech